Literature DB >> 26454748

Outbreak of New Delhi metallo-β-lactamase-1-producing Enterobacter cloacae in an acute care hospital general ward in Singapore.

Hanley J Ho1, Cheng Yen Toh2, Brenda Ang3, Prabha Krishnan4, Raymond T P Lin5, My-Van La6, Angela Chow7.   

Abstract

BACKGROUND: Autochthonous infections with New Delhi metallo-β-lactamase-1 (NDM-1)-producing Enterobacteriaceae have been reported in Singapore since 2011, but occurrences of nosocomial transmission have not. We report an outbreak of NDM-1-producing Enterobacter cloacae among adults admitted to an acute hospital's general ward.
METHODS: On detecting the index case with a culture specimen positive for NDM-1-producing E cloacae, active case finding was conducted by screening all possible patient contacts. On-site ward assessment was performed, and electronic patient medical records were reviewed to conduct a case-control study to identify factors associated with colonization.
RESULTS: Of 55 screened patient contacts, 3 further cases were detected, with isolates genetically related to the index case. None of these 4 cases was housed within the same cubicle. However, 3 were managed by the same medical team. Being managed by this team was positively associated with being a case (adjusted odds ratio = 15.64; 95% confidence interval, 0.91-270.27; P = .06) after adjusting for age, sex, Charlson comorbidity index score, and recent antibiotic use.
CONCLUSION: Our report suggests nosocomial transmission of NDM-1-producing E cloacae occurred via health care staff. Improvements in infection control measures, especially pertaining to staff hand hygiene practices and ward staffing, are needed to reduce the spread of highly resistant pathogens, such as NDM-1-producing Enterobacteriaceae.
Copyright © 2016 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Enterobacter cloacae; Infection control; New Delhi metallo-β-lactamase-1; Outbreaks; Pathogen transmission; Singapore

Mesh:

Substances:

Year:  2015        PMID: 26454748     DOI: 10.1016/j.ajic.2015.08.028

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  5 in total

1.  A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae.

Authors:  Karlijn van Loon; Anne F Voor In 't Holt; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

2.  Spread of Plasmid-Encoded NDM-1 and GES-5 Carbapenemases among Extensively Drug-Resistant and Pandrug-Resistant Clinical Enterobacteriaceae in Durban, South Africa.

Authors:  Torunn Pedersen; John Osei Sekyere; Usha Govinden; Krishnee Moodley; Audun Sivertsen; Ørjan Samuelsen; Sabiha Yusuf Essack; Arnfinn Sundsfjord
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

Review 3.  NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings.

Authors:  Wenjing Wu; Yu Feng; Guangmin Tang; Fu Qiao; Alan McNally; Zhiyong Zong
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

4.  A case-control study of infections caused by Klebsiella pneumoniae producing New Delhi metallo-beta-lactamase-1: Predictors and outcomes.

Authors:  Eduardo Rodríguez-Noriega; Elvira Garza-González; Paola Bocanegra-Ibarias; Beatriz Alejandra Paz-Velarde; Sergio Esparza-Ahumada; Esteban González-Díaz; Héctor R Pérez-Gómez; Rodrigo Escobedo-Sánchez; Gerardo León-Garnica; Rayo Morfín-Otero
Journal:  Front Cell Infect Microbiol       Date:  2022-07-28       Impact factor: 6.073

5.  Epidemiology and Transmission of Carbapenemase-Producing Enterobacteriaceae in a Health Care Network of an Acute-Care Hospital and Its Affiliated Intermediate- and Long-Term-Care Facilities in Singapore.

Authors:  Aung-Hein Aung; Kala Kanagasabai; Jocelyn Koh; Pei-Yun Hon; Brenda Ang; David Lye; Swaine L Chen; Angela Chow
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.